Serena Williams recently shared that she started taking the GLP-1 drug Zepbound after having her two children. The tennis ...

Meanwhile, access to Wegovy has improved slightly compared to last year, due in part to CVS Caremark’s decision to prefer Wegovy on its standard formulary.

The once-daily pill also helped 75 per cent of patients who received the highest dose of orforglipron lower their A1C level - ...

Eli Lilly said on Tuesday its experimental GLP-1 pill helped overweight adults with type 2 diabetes shed 10.5% of body weight ...

Eli Lilly says its weight loss pill orforglipron could win approval this year after a trial showed over 10% weight loss in ...

Novo Nordisk NVO suffered a major setback in July after slashing its 2025 sales and profit outlook, triggering a decline in ...

The TV presenter, 58, shared her concerns for 'impressionable young women' and said the endorsement was a 'betrayal of ...

Makers of weight-loss drugs are expected to rake in more than $150 billion in revenue by the early 2030s, thanks to the ever-growing popularity of Eli Lilly's Zepbound and Novo Nordisk's Wegovy.

Knowledge is power. Covering your eyes and ears and hoping for the best could lead to an early death, and bariatric surgery ...

In a study of more than 1,600 adults with type 2 diabetes, those who received the highest dose of orforglipron on average shed 10.5% of their weight.

Eli Lilly's GLP-1 pill, orforglipron, shows promising trial results for weight loss and type 2 diabetes. Global regulatory ...